Our Take
The pitch is plausible but rests on a vendor's framing: no independent data shows agentic AI actually reduces MSK wait times or prevents the cost escalation the author warns about.
Why it matters
Healthcare systems are hemorrhaging outpatient revenue (down 8% year-over-year per hospital reporting) and struggling with workforce shortages. MSK care is a direct lever: 80% of Americans will face lower back pain, yet conservative treatment remains underinvested until expensive surgery becomes necessary.
Do this week
Hospital operations leaders: audit your current MSK triage workflow and wait-time data before piloting any agentic AI system, so you can establish a baseline to measure whether the tool actually moves patients into care faster.
The physical therapy bottleneck is real and costly
Up to 80% of Americans will experience lower back pain in their lifetime. It is the second-leading cause of hospitalizations and accounts for approximately 83 million lost work days per year, according to the article. Yet demand for physical therapy clinicians far outpaces the rate at which new clinicians enter the workforce.
The result: patients face long wait times, defer treatment, or leak to competing clinics. One hospital report cited in the piece shows outpatient revenue has fallen 8% and inpatient revenue by 3% due to this patient loss.
Hospitals and large clinics are under pressure from multiple directions. The average family health insurance plan cost $26,993 in 2025, up 6% from the prior year, with another 6% increase expected (per recent hospital study cited). Simultaneously, reimbursements often lag inflation while supply costs and workforce shortages compound the burden.
Agentic AI could bridge the capacity gap, but proof is missing
The author argues that agentic AI (AI that takes proactive actions based on patient data without requiring clinician intervention for each step) can help in three ways: triage patients to the right care level quickly, reduce administrative burden on clinicians, and enable hybrid (digital and in-person) delivery models. This flexibility could expand capacity without burning out already-stretched PT teams.
The logic is sound. If AI handles patient intake, appointment scheduling, follow-up reminders, and initial symptom assessment, clinicians gain bandwidth to see more patients or focus on complex cases. Faster triage means fewer patients stuck in the hospital-to-primary-care-to-PT pipeline.
The gap: the article contains no independent benchmark, pilot data, or comparison showing that agentic AI actually reduces wait times, improves patient outcomes, or cuts costs in MSK care. The framing assumes the tool will work as intended. The author leads MedBridge, a digital patient care platform, and the piece appears under MedCity Influencers, a vendor-voice program. No competing data or critical case study is present.
Ask for evidence before committing to agentic AI pilots
The case for AI in MSK care is structurally sound: a labor shortage, a preventable disease, and a cost crisis create room for automation. What is missing is specificity. Before your hospital or clinic invests in agentic AI for MSK triage or patient engagement, request pilot results from vendors or peers who have deployed the tool.
Useful questions: How many patients moved from waiting list to first PT appointment within 48 hours? Did the tool reduce clinician time spent on non-clinical tasks (scheduling, reminders, follow-up calls)? Did patient engagement rates (session adherence, home exercise completion) improve? What was the infrastructure cost and training burden?
The cost pressure is real, and the gap is real. But buying agentic AI to solve a staffing problem is a different problem than buying it to prove it solves staffing. Start with your baseline, define your metric, and hold the vendor to it.